Ajanta Pharma Limited — Cetirizine Exporter Profile
Indian Pharmaceutical Exporter · #3 for Cetirizine · $3.3M export value · DGFT Verified
Ajanta Pharma Limited is the #3 Indian exporter of Cetirizine with $3.3M in export value and 66 verified shipments. Ajanta Pharma Limited holds a 1.9% market share in Cetirizine exports across 4 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Cetirizine Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Cetirizine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.7M | 35 | 66.2% |
| IRAQ | $770.3K | 22 | 29.6% |
| YEMEN, DEMOCRATIC | $64.1K | 6 | 2.5% |
| BOLIVIA | $43.3K | 3 | 1.7% |
Ajanta Pharma Limited exports Cetirizine to 4 countries. The largest destination is PHILIPPINES accounting for 66.2% of Ajanta Pharma Limited's Cetirizine shipments, followed by IRAQ (29.6%) and YEMEN, DEMOCRATIC (2.5%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cetirizine from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $970.3K | 20 |
| THE CATHAY DRUG CO. INC | PHILIPPINES | $550.0K | 11 |
| SHAMS AL-THURAYA CO FOR GENERAL TRA | IRAQ | $378.0K | 11 |
| SHAMS AL-THURAYA CO | IRAQ | $200.0K | 4 |
| THE CATHAY DRUG CO INC | PHILIPPINES | $150.0K | 3 |
| SHAMS AL-THURAYA CO FOR | IRAQ | $82.6K | 2 |
| AL-THURAYA SCIENTIFIC DRUG BUREAU | IRAQ | $66.6K | 3 |
| ALKURAIMI ISLAMIC BANK | YEMEN, DEMOCRATIC | $64.1K | 6 |
| 1286 SEN GIL PUYAT AVENUE CORNER 1 | PHILIPPINES | $50.0K | 1 |
| SHAMS AL THURAYA CO FOR | IRAQ | $43.0K | 2 |
Ajanta Pharma Limited supplies Cetirizine to 12 buyers globally. The largest buyer is AJANTA PHARMA PHILIPPINES INC (PHILIPPINES), followed by THE CATHAY DRUG CO. INC (PHILIPPINES) and SHAMS AL-THURAYA CO FOR GENERAL TRA (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cetirizine Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $82.1M worth of Cetirizine through 8,785 shipments from 649 suppliers to 149 countries, serving 1,814 buyers globally. Ajanta Pharma Limited contributes $3.3M to this total, accounting for 1.9% of India's Cetirizine exports. Ajanta Pharma Limited ships Cetirizine to 4 countries through 12 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Cetirizine Exports?
Ajanta Pharma Limited's average Cetirizine shipment value is $50.0K per consignment, based on 66 shipments totaling $3.3M. The largest destination is PHILIPPINES (66.2% of Ajanta Pharma Limited's Cetirizine exports).
How Does Ajanta Pharma Limited Compare to Other Indian Cetirizine Exporters?
Ajanta Pharma Limited ranks #3 among 649 Indian Cetirizine exporters with a 1.9% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($9.8M), MICRO LABS LIMITED ($7.8M), MARKSANS PHARMA LIMITED ($7.7M). Ajanta Pharma Limited processed 66 shipments to 4 destination countries.
What Cetirizine Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MUBACT L 10/5 TABLETS[23760 X 3 X 10 = 712800 TABLETS][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG TABS]CNOS | $200.5K | 6 |
| ZYKAST TAB 10/5MG[123549PAC X 3 X 10 = 3706470][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABLETS]NOS | $150.0K | 3 |
| MUBACT L 10/5 TABLETS[63036PACKX3X10 = 1891080TABS]MONTELUKAST 10 MG PLUS LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG AS PER INV | $150.0K | 3 |
| ZYKAST TAB 10/5MG[187104 X 3 X 10 = 5613120][MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABLETS]CONT:AS PER INVOICE | $150.0K | 3 |
| ZYKAST 10 5 MG TABLETS 61584 X 3 X 10 1847520 TABS MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS CONT AS PER INVOI | $100.0K | 2 |
| SYNACTIV TAB 5/1 MG[12932PACKx3x10=387960 TABLETS]LEVOCETIRIZINE 5MG+BETAMETHASONE 1MG TABS | $100.0K | 2 |
| SHIPMENT UNDER CONSIGNMENT SALE:APLEV TABLETS 5MG[LEVOCETIRIZINE DIHYDROCHLORIDETABLETS 5MG]22300PACX3X10=669000TABLETSNOS | $66.6K | 3 |
| APLEV TABLETS 5 MG[LEVOCETIRIZINE DIHYDR | $66.6K | 3 |
| CO ALTRIA 10 5 MG TABLETS 56544PACKx3x10 1696320 TABS MONTELUKAST 10 MG PLUS LEVOCETIRIZINE 5 MG TABS EACH AS PER INV | $50.0K | 1 |
| SYNACTIV TAB 5 1 MG 12960PACKx3x10 388800 TABS LEVOCETIRIZINE 5MG BETAMETHASONE1MG TABS | $50.0K | 1 |
Ajanta Pharma Limited exports 45 distinct Cetirizine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MUBACT L 10/5 TABLETS[23760 X 3 X 10 = 712800 TABLETS][MONTE with 6 shipments worth $200.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Ajanta Pharma Limited Compare to Nearest Cetirizine Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | CIPLA LIMITED | $4.3M | 373 | 15 | $11.7K |
| 1 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $4.0M | 80 | 12 | $50.0K |
| 3 | AJANTA PHARMA LIMITED ★ | $3.3M | 66 | 4 | $50.0K |
| 14 | AUROBINDO PHARMA LIMITED | $3.1M | 121 | 5 | $25.4K |
| 15 | GLENMARK PHARMACEUTICALS LIMITED | $2.9M | 115 | 13 | $25.5K |
Ajanta Pharma Limited ranks #3 among 649 Indian Cetirizine exporters. Average shipment value of $50.0K compared to the market average of $126.5K. The closest competitors by value are CIPLA LIMITED and FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Cetirizine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 986 | 11.2% |
| JNPT/ NHAVA SHEVA SEA | 731 | 8.3% |
| JNPT | 616 | 7.0% |
| SAHAR AIR | 542 | 6.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 491 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 408 | 4.6% |
| DELHI AIR | 381 | 4.3% |
| HYDERABAD ICD | 374 | 4.3% |
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Cetirizine Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Cetirizine, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cetirizine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cetirizine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 66 individual customs records matching Ajanta Pharma Limited exporting Cetirizine, covering 45 formulations to 4 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,814+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cetirizine Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Cetirizine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Cetirizine Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cetirizine. For current shipment-level data, contact TransData Nexus.